Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dual inhibitor compounds for use in the treatment of neurodegenerative disorders and alzheimer's disease

Dual inhibitor compounds for use in the treatment of neurodegenerative disorders and alzheimer's disease

US Patent 9975861 · Granted May 22, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyridazinyl amino derivatives as ALK5 inhibitors2025
Amino quinazoline derivatives as P2X3 inhibitors2025
Compounds and compositions for the treatment of tumors2025
Pyrazole derivatives as H4 antagonist compounds2025
Peptide inhibitors targeting the CXCL12/HMGB1 interaction and uses thereof2024
Electrospun fibers for a local release of an anti-inflammatory drug and a promye2024
Methods using fingerprint and evolution analysis2022
Piperazinyl methanone NAAA inhibitors2020
Inhibitors of fatty acid amide hydrolase (FAAH) enzyme with improved oral bioava2019
Benzoxazolone derivatives as acid ceramidase inhibitors, and their use as medica2019
Substituted benzoxazolone derivatives as acid ceramidase inhibitors, and their u2019
Substituted benzoxazolone derivatives as acid ceramidase inhibitors, and their u2019